statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	912
SG - Singapore	130
IT - Italia	113
CN - Cina	68
BR - Brasile	65
RU - Federazione Russa	46
HK - Hong Kong	42
DE - Germania	37
SE - Svezia	34
VN - Vietnam	32
FR - Francia	27
FI - Finlandia	20
IN - India	16
BD - Bangladesh	14
GB - Regno Unito	14
CA - Canada	12
CI - Costa d'Avorio	12
ID - Indonesia	10
PH - Filippine	10
JP - Giappone	7
MX - Messico	7
UA - Ucraina	7
IQ - Iraq	5
NL - Olanda	5
KE - Kenya	4
TR - Turchia	4
AT - Austria	3
CO - Colombia	3
IR - Iran	3
LT - Lituania	3
PT - Portogallo	3
PY - Paraguay	3
UZ - Uzbekistan	3
VE - Venezuela	3
AO - Angola	2
CH - Svizzera	2
EC - Ecuador	2
EG - Egitto	2
ES - Italia	2
MY - Malesia	2
PK - Pakistan	2
PL - Polonia	2
TN - Tunisia	2
TT - Trinidad e Tobago	2
ZA - Sudafrica	2
AE - Emirati Arabi Uniti	1
BE - Belgio	1
BG - Bulgaria	1
BY - Bielorussia	1
CL - Cile	1
GM - Gambi	1
GT - Guatemala	1
HR - Croazia	1
IE - Irlanda	1
IL - Israele	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
MA - Marocco	1
RO - Romania	1
SA - Arabia Saudita	1
SI - Slovenia	1
TW - Taiwan	1
UY - Uruguay	1
VC - Saint Vincent e Grenadine	1
Totale	1.719

Nome	#
Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis	359
Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis	174
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis	172
Host-Cell Type Dependent Features of Recombinant Human Aquaporin-4 Orthogonal Arrays of Particles-New Insights for Structural and Functional Studies	169
Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of Multiple Sclerosis	161
Cerebrospinal Fluid and Clinical Profiles in Adult Type 2–3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience	153
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis	150
Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method	122
Autophagy increase in Merosin-Deficient Congenital Muscular Dystrophy type 1A	111
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity	98
null	62
The role of serum neurofilament light chain in an adult cohort of patients with acquired demyelinating syndromes of the central nervous system (P2-4.006)	32
Serum neurofilament light chain in a cohort of multiple sclerosis, MOG-antibody diseases and neuromyelitis optica spectrum disorders patients	26
Totale	1.789

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	78	1	9	4	2	3	8	2	3	8	4	11	23
2022/2023	131	13	20	11	13	18	12	1	14	19	0	3	7
2023/2024	46	3	7	3	3	2	10	1	5	0	2	0	10
2024/2025	294	13	4	13	8	13	21	34	36	18	31	40	63
2025/2026	756	95	36	58	68	90	49	72	30	97	75	34	52
2026/2027	133	133	0	0	0	0	0	0	0	0	0	0	0
Totale													1.789